Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2023-05-04 00:00:00 ET · period of report 2023-05-02 · accession 0001415889-23-007376 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-04 | 2023-05-02 | TBPH | GRAY SUSANNAH | Dir | A - Grant | $0.00 | +9,132 | 21.0K | +77% | $0 |
| D | 2023-05-04 | 2023-05-02 | TBPH | GRAY SUSANNAH | Dir | A - Grant | $0.00 | +22.0K | 22.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-05-02 | A | A | 9,132 | $0.00 | 20,951 | D | — | — | |
| 2 | Derivative | Share Option (Right to Buy) | 2023-05-02 | A | A | 22,044 | $0.00 | 22,044 | D | $10.95 · — to 2033-05-01 | 22,044 Ordinary Shares | (F1) This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. |